Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03954860Completed
Randomised, open-label trial (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Postoperative blood loss at Day 3, Haemoglobin at Day 3 and 9 more. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03954860.